Drivers of Differential Tx of Anterior Scleritis by Rheumatologists
Uveitis specialists and rheumatologists differ significantly in their most-selected first-choice treatment option for patients with anterior scleritis.
Uveitis
Clinician Roundtable: Effective Management of Noninfectious Uveitis
Autoimmune uveitis is usually a diagnosis of exclusion. Part of the challenge of effective management of noninfectious uveitis is that it is not really a single disease, but a constellation of several diseases.
Shift Towards Prescribing Alternative Biologics for JIA
Researchers have noted a prescribing shift towards the use of alternative biologics that they believe is mostly driven by disease subtype and history of chronic anterior uveitis.
Reduction of Uveitic Flares, Visual Impairment Risk With ADA
Adalimumab significantly lowered risk of uveitic flare in patients with noninfectious uveitis.
VIDEO: Discussion of Prescribing Practices for Uveitis
Allan Gibofsky, MD, attending rheumatologist and Co-director of the Clinic for Inflammatory Arthritis at Hospital for Special Surgery, in New York City, met with Rheumatology Advisor to discuss the recent approval of adalimumab for noninfectious uveitis.
Looking Beyond Corticosteroids to Treat Noninfectious Uveitis
The recent US Food and Drug Administration (FDA) approval of adalimumab (Humira®, AbbVie) for the treatment of noninfectious intermediate, posterior, and pan-uveitis is the first step beyond traditional corticosteroid therapy and toward use of targeted biologics for this rare ocular emergency.
Risk Factors Associated With Increased Uveitis Incidence in AS
Hip-joint lesions, number of affected peripheral arthritis joints, ASO, and CIC were found to be associated with higher rates of uveitis in AS.
Multidisciplinary Partnerships in the Management of Uveitis in Patients With Rheumatic Disease
Uveitis may occur in patients with ankylosing spondylitis, juvenile rheumatoid arthritis, Behcet’s disease, and HLA B27-associated seronegative spondyloarthropathies. Prompt initiation of treatment may improve clinical outcomes, emphasizing the importance of collaboration between rheumatologists and ophthalmologists.
Uveitis Flares In Axial Spondyloarthritis Controlled With Certolizumab Pegol
Uveitis flares occurred at a lower rate in patients treated with certolizumab pegol vs placebo.
- Loading...
Loading...
Next post in Spondyloarthritis
Loading... 
Loading...